Annual reports Annual Report 2022 Annual Report 2021 Annual Report 2020 Annual Report 2019 Annual Report 2018 Annual Report 2017 Annual report 2016 Annual Report 2015 Annual Report 2014 Annual Report 2013 Annual Report 2012 Annual Report 2011
Opstad TB, Papotti B, Åkra S, Hansen CH, Braathen B, Tønnessen T, Solheim S, Seljeflot I (2023) Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD J Transl Med, 21 (1), 644 DOI 10.1186/s12967-023-04518-4, PubMed 37730614 Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023) Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab Open Heart, 10 (2) DOI 10.1136/openhrt-2023-002301, PubMed 37591633 Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023) Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial Clin Nutr, 42 (9), 1657-1660 DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843 More publications
Contact information Group leader: Ida Lunde Address: Oslo Center for Clinical Heart Research – Laboratory, Bld 3, 2nd floor, Department of Cardiology, Clinic of Medicine, Oslo University Hospital Ullevaal, Kirkeveien 166, 0450 Oslo, Norway.